(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. (A) Soluble recombinant FGFR2b extracellular domain significantly inhibits
branching morphogenesis of E13.5 submandibular glands, while rFGFR1b and
rFGFR3c have lesser effects (all 10 µg/ml). Taken together, these results
suggest that multiple FGFRs are involved in branching morphogenesis. (B) The
number of buds was expressed as a ratio of the number of buds at 44
hours/number of buds at 2 hours (T44/T2). At least 5 glands/condition were
used for quantitation, and the experiments were repeated at least three times
(ANOVA, *P<0.05, **P<0.01). (C)
Hematoxylin and Eosin stained sections show that although rFGFR2b inhibits
branching and end bud formation, duct and lumen formation (arrows) still
occur. The higher magnification shows duct lumen formation. See Movie 1 in
supplementary material of control and rFGFR2b-treated SMGs cultured for 36
hours.